Stay updated on Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.

Latest updates to the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%
- Check19 days agoChange DetectedPage content remains largely the same, with a version bump to v3.1.0 and removal of several older MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag (v3.0.2).SummaryDifference0.7%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as topics related to drug safety. However, many specific location entries have been removed, indicating a potential consolidation of information.SummaryDifference3%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine in Acromegaly: Safety and Efficacy Clinical Trial page.